Difficult Menopause Could Be Warning Sign For Future Dementia
By Dennis Thompson HealthDay Reporter
THURSDAY, March 6, 2025 -- Hot flashes, night sweats and other symptoms of a difficult menopause could be early warning flags for dementia, a new study suggests.
Women who exhibit more menopause symptoms are more likely to develop early signs of dementia like decreased mental function and mild behavioral impairment, compared with women who have an easier transition, researchers reported in the journal PLOS One.
Results also showed that hormone replacement therapy did help ease the effects of menopause on behavioral impairment.
“It's fascinating that there is a link between the menopausal experience and subsequent changes in cognition and behavior,” senior investigator Dr. Zahinoor Ismail, a neuropsychiatrist at the University of Calgary in Canada, said in a news release. “I find that mind blowing.”
Women are known to have triple a man's risk of developing Alzheimer’s disease and related dementias, researchers said in background notes.
To examine this risk more closely, researchers analyzed data on nearly 900 women who’d gone through menopause.
The women reported the symptoms they suffered during menopause, and took tests measuring their brain function and behavior.
Symptoms of menopause could include irregular periods, hot flashes, chills, vaginal dryness, weight gain, slowed metabolism, night sweats, sleep problems, mood symptoms, inattention or forgetfulness and other unnamed symptoms, researchers said.
Women who reported more menopause symptoms tended to have more cognitive impairment later in life, researchers found.
They also had more behavioral problems associated with dementia, such as apathy, anxiety, irritability, lack of inhibition, loss of social graces or tact or inflexibility.
Researchers also asked women if they’d used hormone replacement therapy, which can ease the symptoms of menopause.
Those who had used hormone therapy had better behavioral impairment scores, but the therapy did not improve their cognitive scores, results show.
Some have speculated that the decline in estrogen levels caused by menopause might affect later brain health, researchers said.
Estradiol, a form of estrogen, is known to contribute to the development of synapses and neurons, “all of which decline in neurodegenerative diseases and dementia,” researchers wrote.
“In menopause, estradiol naturally declines,” the research team wrote. “Thus, the experience of menopausal symptoms may act as an indicator of how well females tolerate estradiol changes.”
However, they added that more research involving a larger group of women is needed to verify these findings, and to better understand the potential effects of menopause on brain health.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-07 00:00
Read more

- FDA Approves Gomekli (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
- FDA Approves TNKase for Acute Ischemic Stroke
- Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer
- Lumpectomy Preserves Sexual Well-Being Among Breast Cancer Patients
- Cancer Incidence, Mortality Rates Declining in Appalachia
- Study IDs Factors Linked to Risk for Transfer From Peritoneal Dialysis to Hemodialysis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions